SIGN UP or LOGIN
YOUR CART
SUPPORT

Happy Thanksgiving!
Please note that our call center will be closed on Thursday November 24

  • US Name:

    Relafen

  • Israeli Names:

    Nabuco, Reliflex

  • Active Ingredients:

    Nabumetone

  • Brand Manufacturer:

    GSK

  • Manufacturer Location:

    Israel

  • Click here to view Product Insert

Relafen

Nabumetone is a non-steroidal anti-inflammatory drug (NSAID). NSAIDs are used to relieve pain and inflammation.

Brand Reliflex500mg20 Tablets 9311 GSK 483
-
+
$25.30
spinner
Generic Nabuco 500mg20 Tablets22546 UniPharm 482
-
+
$11.00
spinner

Nabumetone works by blocking the action of a substance in the body called cyclo-oxygenase (COX). Cyclo-oxygenase is involved in the production of various chemicals in the body, some of which are known as prostaglandins. Prostaglandins are produced by the body in response to injury and certain diseases and conditions, and cause pain, swelling and inflammation. Nabumetone blocks the production of these prostaglandins and is therefore effective at reducing inflammation and pain.

Required

Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Typically Under 7 days

Innovative Medicine

Innovative Medicine from Israel

In the month of May just past, there were a number of exciting new developments in the area of pharmaceutical research announced or released by the Israeli “Start-up Nation” medical research community. Cancer therapies One

Read More »
buy creon

What Are the Side Effects of Creon?

People who have been diagnosed as suffering from Exocrine Pancreatic Insufficiency (EPI) may have been prescribed the drug Creon. EPI occurs when the pancreas doesn’t produce enough digestive enzymes and as a result the body

Read More »
macular degeneration causes

Israel Studies on Macular Degeneration

Age-related macular degeneration is the leading cause of blindness for those over the age of 60. While there are some treatments which can help reduce the progression of the disease, there is currently no cure.

Read More »